14.04.2021
LUMIBIRD MEDICAL’S GLAUCOMA TREATMENT POTENTIAL FURTHER STRENGTHENED BY THE LATEST EGS RECOMMENDATIONS
The European Glaucoma Society (EGS), the world’s foremost learned society for glaucoma and its treatments, issued recommendations in its fifth “Terminology and Guidelines for Glaucoma” report, published in March 2021, that validate the positioning and relevance of the solutions developed by LUMIBIRD Medical. EGS officially added SLT...